key: cord-1033372-fc86sjec authors: Daniel, Y; Hunt, BJ; Retter, A; Henderson, K; Wilson, S; Sharpe, CC; Shattock, MJ title: Haemoglobin Oxygen Affinity in Patients with Severe COVID‐19 Infection date: 2020-05-26 journal: Br J Haematol DOI: 10.1111/bjh.16888 sha: 905670d168b4c994a3a6d9cd0ebd12d894aa8410 doc_id: 1033372 cord_uid: fc86sjec During critical care, at least until the late stage of the disease, severely ill COVID‐19 patients may have relatively well preserved lung compliance but remain severely hypoxaemic. A recent theoretical study suggested a direct interaction between COVID‐19 viral proteins and haemoglobin (Hb) that could lead to a loss of oxygen carrying capacity. As national guidelines strongly support a restrictive transfusion strategy in the critically ill, any right‐shift in the Hb O(2) affinity curve could contribute to the hypoxaemia and be potentially harmful. We have measured Hb O(2) affinity curves from severely ill COVID‐19 patients and, in comparison to age‐ and sex‐matched controls, find no evidence for a shift in O(2) affinity that would support any change in clinical management. 2 conserved until late in the disease course. Despite early preservation of lung compliance, the hypoxaemia in COVID-19 is severe and is ultimately the primary mechanism of multiple organ failure and death (Gattinoni et al. 2020 ). The underlying pathology is due to COVID-19 entering cells via the ACE2 receptor. This receptor is expressed on many cells including alveolar epithelial cells and vascular endothelium resulting in a profound immune response and widespread endothelial dysfunction (Connors and Levy 2020). We were both interested and concerned to read the report by Lui and Li (2020). This in silico study used homology modelling and molecular docking algorithms to predict theoretical interactions between COVID-19 and haemoglobin (Hb). COVID-19 expresses a variety of open reading frame proteins including orf1ab, ORF3a, ORF6, ORF7a, ORF10 and ORF8. Lui and Li (2020) predict that these ORF proteins can interact with haemoglobin to reduce both oxygen (O2) affinity and total haemoglobin content. They report specifically that their modelling predicts a theoretical interaction between orf1ab, ORF10 and ORF3a and the haem moiety of the beta chain while ORF8 and viral surface glycoproteins can directly target the porphyrin. They assert that their data supports the use of chloroquine and hydroxychloroquine as therapeutic agents. However, the methods used by Lui and Li have very recently been criticised -not least of all because they are unsupported by experimental evidence (Read 2020). It is unclear what testable physiological consequences might arise from an interaction between viral proteins and Hb but these are presumed to include a generalised loss This article is protected by copyright. All rights reserved Accepted Article 3 Multiple studies and national guidelines strongly support restrictive transfusion practice in the critically ill as a basic standard of care (Retter et al. 2020) . It is possible that if the haemoglobin molecule was adversely affected by COVID-19, and the O2 affinity curve right-shifted, restrictive transfusion could be potentially harmful. Given the very high mortality of these ventilated COVID-19 patients, we considered evaluation of any effect on the O2 affinity curve as urgent to inform our practice. Physicians caring for patients infected with COVID-19 ordered an Hb O2 affinity assessment in 14 patients (4 newly admitted from the emergency department and 10 patients receiving mechanical ventilation in critical care which we compared to 11 ageand sex-matched controls as part of an audit to assess the utility of this investigation in the management of patients with severe disease (Guys and St Thomas' Hospital Audit No. 10855) ( Table 1 ). No extra samples or blood tests were taken from patients -rather relevant samples were identified after a routine full blood count had been reported. O2 saturation curves from control and COVID-19 positive patients are shown in Figure 1 . It is clear that there are no differences in O2 affinity or co-operativity between samples from COVID-19 and matched controls. The P50 and Hill Slope values are given in Table 1 . However, as is common in critically ill patients, there is a substantial anaemia and loss of total haemoglobin. In summary, while the total O2 carrying capacity will certainly be reduced by the anaemia and loss of total haemoglobin, we see no evidence, using standard clinical measures in a small cohort of patients, to suggest that COVID-19 alters haemoglobin O2 affinity and there is no requirement to change our transfusion practice. COVID-19 and its implications for thrombosis and anticoagulation COVID-19 pneumonia: different respiratory treatment for different phenotypes? Clinical Characteristics of Coronavirus Disease 2019 in China; China Medical Treatment Expert Group for Covid-19 Clinical features of patients infected with 2019 novel coronavirus in Wuhan COVID-19: Attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism ARDS Definition Task Force (2012) Acute Respiratory distress syndrome: the Berlin definition Flawed methods in "Attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism British Committee for Standards in Haematology (2013) Guidelines on the management of anaemia and red cell transfusion in critically ill adult patients